Your browser doesn't support javascript.
loading
A prognostic signature consisting of N6-methyladenosine modified mRNAs demonstrates clinical potential in prediction of biochemical recurrence and guidance on precision therapy in prostate cancer.
Lu, Jianming; Chen, Jiahong; Lin, Zhuoyuan; Liu, Qinwei; Zhong, Chuanfan; Cai, Zhouda; Jia, Zhenyu; Zhong, Weide; Liang, Yingke; Cai, Chao.
Afiliación
  • Lu J; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University; Guangdong Key Laboratory of Urology; Guangzhou, Guangdong 510230, China; Department of Andrology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180
  • Chen J; Department of Urology, Huizhou Municipal Central Hospital, Huizhou, Guangdong 516001, China.
  • Lin Z; Department of Urology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China.
  • Liu Q; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University; Guangdong Key Laboratory of Urology; Guangzhou, Guangdong 510230, China.
  • Zhong C; Department of Urology, Zhujiang Hospital, Southern Medical University, Guangzhou, Guangdong 510282, China.
  • Cai Z; Department of Andrology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
  • Jia Z; Department of Botany and Plant Sciences, University of California, Riverside, CA 92521, USA.
  • Zhong W; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University; Guangdong Key Laboratory of Urology; Guangzhou, Guangdong 510230, China; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou
  • Liang Y; Department of Urology, Guangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou 510180, China.
  • Cai C; Department of Urology, Minimally Invasive Surgery Center, The First Affiliated Hospital of Guangzhou Medical University; Guangdong Key Laboratory of Urology; Guangzhou, Guangdong 510230, China. Electronic address: chaocai85@hotmail.com.
Transl Oncol ; 33: 101670, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37060728
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Oncol Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Transl Oncol Año: 2023 Tipo del documento: Article